Relay Therapeutics Inc. (RLAY) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Relay Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Relay Therapeutics Inc. (RLAY) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $4.1B. It trades at $19.69, up 4.51% today. 9 analysts' average target of $27.00 implies +37.1% from today's price. Kronos AI's 30-day forecast is +0.2% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $27.00 |
| Low – high | $20.00 – $31.00 |
| Analysts | 9 |
| Upside to average | +37.1% |
Kronos AI 30-day forecast
| Expected close | $18.88 (+0.2%) |
| Likely range | −10.3% … +4.3% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator